Issue share to retail holder, page-11

For a starter, the USA BNOEF OTC AUD equivalent share price is 17 cents and trending higher.

The accelerated capital raising is there to reward current shareholders and provide sufficient funds to get the R&D to the next level.

Things are looking really positive here and it is refreshing to see a company rewarding retail investors on the same playing field as institutional investors.

Bionomics is kicking goals right now. There are a lot of reasons for the share price to rise from here. Looking forward to some material updates over the ensuing weeks and months.

Game on.